» Articles » PMID: 38560459

The Clinical Association of Programmed Death-1/PD-L1 Axis, Myeloid Derived Suppressor Cells Subsets and Regulatory T Cells in Peripheral Blood of Stable COPD Patients

Overview
Journal PeerJ
Date 2024 Apr 1
PMID 38560459
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Myeloid-derived suppressor cells (MDSCs) have crucial immunosuppressive role in T cell dysfunction in various disease processes. However, the role of MDSCs and their impact on Tregs in COPD have not been fully understood. The aim of the present study is to investigate the immunomodulatory role of MDSCs and their potential impact on the expansion and function of Tregs in COPD patients.

Methods: Peripheral blood samples were collected to analyze circulating MDSCs, Tregs, PD-1/PD-L1 expression to assess the immunomodulatory role of MDSC and their potential impact on the expansion and function of Treg in COPD. A total of 54 COPD patients and 24 healthy individuals were enrolled in our study. Flow cytometric analyses were performed to identify granulocytic MDSCs (G-MDSCs), monocytic MDSCs (M-MDSCs), Tregs, and the expression of PD-1/PD-L1(L2) on MDSCs and Tregs in peripheral blood.

Results: Our results revealed a significantly higher percentage of G-MDSCs and M-MDSCs ( < 0.001) in COPD patients compared to the healthy controls. Additionally, a significantly higher proportion of peripheral blood Tregs was observed in COPD patients. Furthermore, an increased expression of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on Tregs ( < 0.01) was detected in COPD patients. The expression of PD-1 on CD4 Tcells and Tregs, but not CD8Tcells, was found to be increased in patients with COPD compared to controls. Furthermore, an elevated expression of PD-L1 on M-MDSCs ( < 0.01) was also observed in COPD patients. A positive correlation was observed between the accumulation of M-MDSCs and Tregs in COPD patients. Additionally, the percentage of circulating M-MDSCs is positively associated with the level of PD-1 (r = 0.51, < 0.0001) and CTLA-4 (r = 0.42, = 0.0014) on Tregs in COPD.

Conclusion: The recruitment of MDSCs, accumulation of Tregs, and up-regulation of CTLA-4 on Treg in COPD, accompanied by an increased level of PD-1/PD-L1, suggest PD-1/PD-L1 axis may be potentially involved in MDSCs-induced the expansion and activation of Treg at least partially in COPD.

Citing Articles

Increased CD14HLA-DR myeloid-derived suppressor cells can be regarded as a biomarker on disease severity and response to therapy in acute coronary syndrome.

Tan Y, Ren M, Hou J, Hou T, Lin X PeerJ. 2024; 12:e18154.

PMID: 39399429 PMC: 11468897. DOI: 10.7717/peerj.18154.

References
1.
Calles A, Liao X, Sholl L, Rodig S, Freeman G, Butaney M . Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer. J Thorac Oncol. 2015; 10(12):1726-35. DOI: 10.1097/JTO.0000000000000687. View

2.
Scrimini S, Pons J, Agusti A, Clemente A, Sallan M, Bauca J . Expansion of myeloid-derived suppressor cells in chronic obstructive pulmonary disease and lung cancer: potential link between inflammation and cancer. Cancer Immunol Immunother. 2015; 64(10):1261-70. PMC: 11029165. DOI: 10.1007/s00262-015-1737-x. View

3.
Gong H, Liu T, Chen W, Zhou W, Gao J . Effect of IRAK-M on Airway Inflammation Induced by Cigarette Smoking. Mediators Inflamm. 2017; 2017:6506953. PMC: 5603328. DOI: 10.1155/2017/6506953. View

4.
Sakaguchi S, Mikami N, Wing J, Tanaka A, Ichiyama K, Ohkura N . Regulatory T Cells and Human Disease. Annu Rev Immunol. 2020; 38:541-566. DOI: 10.1146/annurev-immunol-042718-041717. View

5.
Deshane J, Redden D, Zeng M, Spell M, Zmijewski J, Anderson J . Subsets of airway myeloid-derived regulatory cells distinguish mild asthma from chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2014; 135(2):413-424.e15. PMC: 4323991. DOI: 10.1016/j.jaci.2014.08.040. View